REG - Haleon PLC - Director/PDMR Shareholding
Today 13:30
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250926:nRSZ0535Ba&default-theme=true
RNS Number : 0535B Haleon PLC 26 September 2025
Haleon plc: Director/PDMR Shareholding
26 September 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by Persons
Discharging Managerial Responsibilities ("PDMRs").
On 25 September 2025, the Company was notified of the following transactions
as detailed below.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dawn Allen
2 Reason for the notification
a) Position/status Chief Financial Officer - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code
GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.31963 1186.71154
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Keith Choy
2 Reason for the notification
a) Position/status President, Asia Pacific - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.31963 3749.41677
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Filippo Lanzi
2 Reason for the notification
a) Position/status President, EMEA and LATAM - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code
GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.31963 2356.42498
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Brian McNamara
2 Reason for the notification
a) Position/status Chief Executive Officer - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code
GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.31963 5693.56923
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Haleon plc American Depositary Shares (ADS)
Identification code
US4055521003
b) Nature of the transaction Acquisition of ADSs as a result of dividend reinvestment
c) Price(s) and volume(s)
Price(s) Volume(s)
$8.99986 2026.50806
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 23 September 2025
f) Place of the transaction New York Stock Exchange (XNYS)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Edward Petter
2 Reason for the notification
a) Position/status Chief Corporate Affairs Officer - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code
GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.31963 576.54018
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Tamara Rogers
2 Reason for the notification
a) Position/status Chief Marketing Officer - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code
GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares as a result of dividend reinvestment
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.31963 1906.13339
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 23 September 2025
f) Place of the transaction London Stock Exchange (XLON)
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans six major categories - Oral Health, Vitamins, Minerals and Supplements
(VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin
Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on
trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com (http://www.haleon.com/)
.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBBGDCXUDDGULRecent news on HALEON
See all newsREG - Haleon PLC - Director/PDMR Shareholding
AnnouncementREG - Haleon PLC - Transaction in Own Shares
AnnouncementREG - Haleon PLC - Transaction in Own Shares
AnnouncementREG - Haleon PLC - Holding(s) in Company
AnnouncementREG - Haleon PLC - Transaction in Own Shares
Announcement